1. Home
  2. CZFS vs SABS Comparison

CZFS vs SABS Comparison

Compare CZFS & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Financial Services Inc.

CZFS

Citizens Financial Services Inc.

HOLD

Current Price

$83.00

Market Cap

288.7M

Sector

Finance

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.80

Market Cap

263.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CZFS
SABS
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.7M
263.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
CZFS
SABS
Price
$83.00
$3.80
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
26.1K
481.3K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
3.10%
N/A
EPS Growth
30.26
78.53
EPS
4.28
N/A
Revenue
$9,881,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.64
N/A
P/E Ratio
$19.23
N/A
Revenue Growth
2.82
N/A
52 Week Low
$52.35
$1.85
52 Week High
$83.37
$5.15

Technical Indicators

Market Signals
Indicator
CZFS
SABS
Relative Strength Index (RSI) 65.62 54.76
Support Level $55.53 $3.68
Resistance Level $83.37 $4.09
Average True Range (ATR) 3.12 0.17
MACD 0.32 0.03
Stochastic Oscillator 90.93 72.58

Price Performance

Historical Comparison
CZFS
SABS

About CZFS Citizens Financial Services Inc.

Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

Share on Social Networks: